EKSO - Ekso Bionics Holdings, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue11,3327,35314,2218,661
Cost of Revenue7,0235,28410,3637,482
Gross Profit4,3092,0693,8581,179
Operating Expenses
Research Development5,1288,9978,4796,138
Selling General and Administrative24,44624,35721,15016,602
Non Recurring----
Total Operating Expenses36,59738,63839,99230,222
Operating Income or Loss-25,265-31,285-25,771-21,561
Income from Continuing Operations
Total Other Income/Expenses Net-1,7272,1632,3011,971
Earnings Before Interest and Taxes-25,265-31,285-25,771-21,561
Interest Expense-600-648-16-13
Income Before Tax-26,992-29,122-23,470-19,590
Income Tax Expense----
Minority Interest----
Net Income From Continuing Ops-26,992-29,122-23,470-19,590
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-26,992-29,122-23,470-19,590
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-26,992-29,122-33,815-24,245